Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using PTCy.

Mariam T Nawas, Annie Im, Brian Shaffer
Author Information
  1. Mariam T Nawas: Hematopoietic Cellular Therapy Program, Department of Medicine, University of Chicago Medicine, Chicago, IL. ORCID
  2. Annie Im: University of Pittsburgh/UPMC Hillman Cancer Center, Pittsburgh, PA.
  3. Brian Shaffer: Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Abstract

No abstract text available.

References

  1. Biol Blood Marrow Transplant. 2015 May;21(5):889-93 [PMID: 25662230]
  2. Bone Marrow Transplant. 2021 Jul;56(7):1683-1690 [PMID: 33658647]
  3. Biol Blood Marrow Transplant. 2016 Oct;22(10):1851-1860 [PMID: 27318038]
  4. Leuk Lymphoma. 2009 Sep;50(9):1434-41 [PMID: 19603344]
  5. Am J Hematol. 2020 Aug;95(8):892-899 [PMID: 32303111]
  6. N Engl J Med. 2013 Jan 17;368(3):288 [PMID: 23323911]
  7. Biol Blood Marrow Transplant. 2020 Aug;26(8):1459-1468 [PMID: 32434056]
  8. Bone Marrow Transplant. 2018 Dec;53(12):1522-1531 [PMID: 29703966]
  9. Transplant Cell Ther. 2022 Feb;28(2):111.e1-111.e8 [PMID: 34844022]
  10. Haematologica. 2016 Apr;101(4):499-505 [PMID: 26768686]
  11. Oncotarget. 2016 May 10;7(19):27255-66 [PMID: 27036034]
  12. Biol Blood Marrow Transplant. 2008 Apr;14(4):449-57 [PMID: 18342788]
  13. Biol Blood Marrow Transplant. 2019 Dec;25(12):2431-2437 [PMID: 31394272]
  14. Biol Blood Marrow Transplant. 2018 Aug;24(8):1664-1670 [PMID: 29680516]
  15. Biol Blood Marrow Transplant. 2012 Dec;18(12):1859-66 [PMID: 22863841]

Grants

  1. P30 CA008748/NCI NIH HHS

MeSH Term

Humans
Transplantation, Haploidentical
Cyclophosphamide
Hematopoietic Stem Cell Transplantation
Bronchiolitis Obliterans Syndrome
Graft vs Host Disease

Chemicals

Cyclophosphamide

Word Cloud

Created with Highcharts 10.0.0HighergraftcelldoseinfluencedevelopmentacutechronicGVHDhaploidenticaltransplantationusingPTCy

Similar Articles

Cited By